4 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 9 Phase 2, 5 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 4, Terminated 2, Active not recruiting 1, Recruiting 1, Unknown 1 |
| Phase 3 | 5 | Completed 3, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow KCRI: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases MesoCellA-Ortho administration, HA administration - Osteoarthritis of Knee | Phase 1 / Phase 2 | Completed | Jagiellonian University | 192 | 2022-01-05 | 2024-03-21 |
| Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes Cladribine - Acute Myeloid Leukemia Myelodysplastic Syndromes | Phase 2 | Active not recruiting | Maria Sklodowska-Curie National Research Institute of Oncology | 40 | 2021-10-07 | 2025-04-24 |
| Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL" Obinutuzumab, Rituximab - CD20-positive Acute Lymphoblastic Leukemia | Phase 2 | Terminated | Maria Sklodowska-Curie National Research Institute of Oncology | 49 | 2021-10-05 | 2026-11-17 |
| Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment Opdivo - Nasopharyngeal Cancer | Phase 2 | Recruiting | Maria Sklodowska-Curie National Research Institute of Oncology | 32 | 2021-08-26 | 2026-10-20 |
| Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI) CardioCell, Placebos - Critical Limb Ischemia | Phase 2 / Phase 3 | Unknown | John Paul II Hospital, Krakow | 50 | 2018-04-19 | 2021-04-09 |
| Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF) CardioCell, Placebos - Heart Failure | Phase 2 / Phase 3 | Completed | John Paul II Hospital, Krakow | 115 | 2018-04-19 | 2021-04-09 |
| Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI) Cardiac Drug, Placebos - Myocardial Infarction | Phase 2 / Phase 3 | Completed | John Paul II Hospital, Krakow | 105 | 2017-10-20 | 2021-04-09 |
| A Clinical Evaluation of the ProNOVA XR Polymer Free Drug Eluting Coronary Stent System Drug Eluting Stent implantation - Myocardial Ischemia | Phase 2 / Phase 3 | Completed | KCRI | 50 | 2008-11-01 | 2011-01-20 |
| ThromboAblation in Acute Myocardial Infarction Laser Thromboablation, PTCA (Direct Stenting) - ST Elevation Acute Myocardial Infarction | Phase 2 / Phase 3 | Terminated | KCRI | 78 | 2008-03-01 | 2011-01-20 |
Chronic Limb-Threatening Ischemia (1) · Diabetes Mellitus, Type 2 (1) · Heart Failure (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Nasopharyngeal Neoplasms (1) · Obesity (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1) · ST Elevation Myocardial Infarction (1) · Thrombosis (1)
Cardiovascular Agents (1) · Cladribine (1) · Nivolumab (1) · Rituximab (1) · obinutuzumab (1)
Poland (9)
Dariusz Dudek, MD, PhD (2) · Krzysztof Ficek, Prof., MD, PhD, DSc (1)
2019 (1)